PubMed · 7836344
Lithium: the present and the future.
Abstract
In summary, Dr. Keck reported that the literature as a whole shows lithium, valproate, and carbamazepine to be about comparable in treating acute mania. Lithium appears to be clearly efficacious for the treatment of acute bipolar depression; valproate has shown equivocal results, and carbamazepine weakly positive results, when used to treat this condition. Results of controlled studies show that maintenance therapy with lithium is effective in preventing recurrence of manic depressive illness; results of valproate for maintenance therapy are pending; and carbamazepine therapy can be effective but less so compared to lithium.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
1995. Lithium: the present and the future.. https://pubmed.ncbi.nlm.nih.gov/7836344/
Cite the original work for its findings. Save a collection to share your selection of sources.